|Substance Use and Preconception Care: A Review of the Literature|
|Nila Ricks1, Louise Comer2, Fuqin Liu2, Heather DeGrande2, Olusola Adeniran2|
|1Texas Woman’s University, Denton, Texas, USA
2College of Nursing, Texas Woman’s University, Denton, Texas, USA
IJWHR 2017; 5: 03-10
Viewed : 1224 times
Downloaded : 1602 times.
Keywords : Preconception care, Substance use, Pre-pregnancy health
|Full Text(PDF) | Related Articles|
Substance use has detrimental effects on reproductive health, especially on pregnancy outcomes. In this paper, we review the literature on substance use among both men and women during the preconception period. Preconception care (PCC) is increasingly recognized as a vital component of optimal maternal and infant health outcomes. The US Centers for Disease Control and Prevention (CDC) issued recommendations of PCC that include risk reduction before conception. There is a gap in the literature regarding substance use during the preconception period, however, as the emphasis on risk reduction before conception has focused mainly on women and selected substances. Further, there is a need to understand the existing evidence on substance use related disparity issues such as who has the highest prevalence, who has the worse effects, and who is least likely to get screened and treated. An understanding of these disparity issues is critical to effective PCC and optimal pregnancy outcomes.
Cite By, Google Scholar